To the Editor: A 62-year-old woman was admitted on 10 January 2012 for cardiac monitoring after her implantable cardioverter–defibrillator (ICD) discharged four times over a few hours. She had a history of ventricular tachycardia due to ischaemic cardiomyopathy, and had had an ICD (D284DRG Maximo II DR, Medtronic, Minneapolis, Minn, USA) inserted 6 years earlier. Her ICD had not previously discharged since insertion. Her medical history included hypertension and emphysema. Interrogation of the device revealed that during the defibrillator shocks, the patient was in sinus rhythm, and the ICD was double counting tall T-waves as R-waves (Box). She did not have ventricular tachycardia or fibrillation. The T-waves suggested underlying hyperkalaemia, and her serum potassium level was 6.2 mmol/L (reference interval, 3.5–5.0 mmol/L). It was discovered that, 1 month before presenting at our hospital, she had been started on potassium replacement therapy to treat a serum potassium level of 3.7 mmol/L, and had not undergone follow-up blood tests. We discontinued the patient’s potassium replacement therapy and treated her hyperkalaemia with oral potassium-binding resin. After correction of the hyperkalaemia, the patient’s T-wave morphology normalised, and there were no further inappropriate shocks.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.